Thrombosis
News
RBC transfusions with surgery may increase VTE risk
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
News
DOAC’s edge over warfarin fades with low adherence
BOSTON –
Clinical
Skip the catheter-directed thrombolytics
Does the addition of catheter-directed thrombolysis to standard therapy with anticoagulation reduce the risk of the postthrombotic syndrome in...
Clinical
LAAC in nonvalvular AF provides stroke protection comparable to warfarin
Is mechanical left atrial appendage closure (LAAC) as effective as warfarin at preventing stroke in patients with nonvalvular atrial fibrillation...
News
Design limitations may have compromised DVT intervention trial
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
News
Does warfarin cause acute kidney injury?
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
News
Impaired kidney function no problem for dabigatran reversal
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
News
VTE risk after bariatric surgery should be assessed
SEATTLE – Thromboelastometry can play a role in identifying bariatric surgery patients at risk for VTE.
News
The ‘holy grail’ of thrombosis prevention
SAN DIEGO – One expert says it’s the ability to determine the risk of recurrence with or without continuation of anticoagulant treatment.
